TRIOSTAT Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Triostat, and what generic alternatives are available?
Triostat is a drug marketed by Par Sterile Products and is included in one NDA.
The generic ingredient in TRIOSTAT is liothyronine sodium. There are four drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the liothyronine sodium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Triostat
A generic version of TRIOSTAT was approved as liothyronine sodium by XGEN PHARMS on August 17th, 2005.
Summary for TRIOSTAT
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 76 |
Clinical Trials: | 2 |
Patent Applications: | 1,261 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for TRIOSTAT |
What excipients (inactive ingredients) are in TRIOSTAT? | TRIOSTAT excipients list |
DailyMed Link: | TRIOSTAT at DailyMed |
Recent Clinical Trials for TRIOSTAT
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Seattle Children's Hospital | Phase 3 |
Michael Portman | Phase 3 |
Anatomical Therapeutic Chemical (ATC) Classes for TRIOSTAT
US Patents and Regulatory Information for TRIOSTAT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Par Sterile Products | TRIOSTAT | liothyronine sodium | INJECTABLE;INJECTION | 020105-001 | Dec 31, 1991 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |